share_log

HC Wainwright & Co. Reiterates Buy on Zentalis Pharma, Maintains $10 Price Target

Benzinga ·  Mar 17 11:14

HC Wainwright & Co. analyst Andrew Fein reiterates Zentalis Pharma (NASDAQ:ZNTL) with a Buy and maintains $10 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 227

Recommended

Write a comment